ArticleJournal of experimental & clinical cancer research : CR2015

Cancer-related CD15/FUT4 overexpression decreases benefit to agents targeting EGFR or VEGF acting as a novel RAF-MEK-ERK kinase downstream regulator in metastatic colorectal cancer.

Guido Giordano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.